Laurie Stelzer

Insider Reports History

Identity 1 identity field
Location
Waltham, MA
SEC source record 1 source field
Owner filing signature
/s/ Heidy King-Jones, as Attorney-in-Fact
Source evidence 1 source field

Reported holdings for Laurie Stelzer

Form 4 holding Chief Financial Officer

Mirati Therapeutics, Inc.

Security class
Common Stock
Shares / value
102,312
Estimated value
$6,038,454
Report date
09 Aug 2023
Price
$59.02
Ownership
Direct
Form 4 holding Director

MBX Biosciences, Inc.

Security class
Stock option (right to buy)
Shares / value
32,000
Estimated value
Report date
20 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Surface Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
24,000
Estimated value
Report date
08 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sionna Therapeutics, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
19,959
Estimated value
Report date
12 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP & Chief Financial Officer

ARENA PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
$98.51
Ownership
Direct
Form 4 holding EVP & Chief Financial Officer

ARENA PHARMACEUTICALS INC

Security class
Employee Performance Restricted Stock Unit
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP & Chief Financial Officer

ARENA PHARMACEUTICALS INC

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Laurie Stelzer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .